Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Comparison of a Short Versus Long Stokes Shift Near-Infrared Dye During Intraoperative Molecular Imaging.

Corbett CJ, Frenzel Sulyok LG, Predina JD, Newton AD, Bryski MG, Xia L, Stadanlick J, Shin MH, Mahalingam SM, Low PS, Singhal S.

Mol Imaging Biol. 2020 Feb;22(1):144-155. doi: 10.1007/s11307-019-01434-2.

PMID:
31820349
2.

Phenotypic and functional analysis of malignant mesothelioma tumor-infiltrating lymphocytes.

Klampatsa A, O'Brien SM, Thompson JC, Rao AS, Stadanlick JE, Martinez MC, Liousia M, Cantu E, Cengel K, Moon EK, Singhal S, Eruslanov EB, Albelda SM.

Oncoimmunology. 2019 Jul 13;8(9):e1638211. doi: 10.1080/2162402X.2019.1638211. eCollection 2019.

PMID:
31428531
3.

Human tumor-associated monocytes/macrophages and their regulation of T cell responses in early-stage lung cancer.

Singhal S, Stadanlick J, Annunziata MJ, Rao AS, Bhojnagarwala PS, O'Brien S, Moon EK, Cantu E, Danet-Desnoyers G, Ra HJ, Litzky L, Akimova T, Beier UH, Hancock WW, Albelda SM, Eruslanov EB.

Sci Transl Med. 2019 Feb 13;11(479). pii: eaat1500. doi: 10.1126/scitranslmed.aat1500.

4.

Identification of a Folate Receptor-Targeted Near-Infrared Molecular Contrast Agent to Localize Pulmonary Adenocarcinomas.

Predina JD, Newton AD, Connolly C, Dunbar A, Baldassari M, Deshpande C, Cantu E 3rd, Stadanlick J, Kularatne SA, Low PS, Singhal S.

Mol Ther. 2018 Feb 7;26(2):390-403. doi: 10.1016/j.ymthe.2017.10.016. Epub 2017 Oct 26.

5.

Human lung tumor FOXP3+ Tregs upregulate four "Treg-locking" transcription factors.

Akimova T, Zhang T, Negorev D, Singhal S, Stadanlick J, Rao A, Annunziata M, Levine MH, Beier UH, Diamond JM, Christie JD, Albelda SM, Eruslanov EB, Hancock WW.

JCI Insight. 2017 Aug 17;2(16). pii: 94075. doi: 10.1172/jci.insight.94075. eCollection 2017 Aug 17.

6.

Rpl22 Loss Selectively Impairs αβ T Cell Development by Dysregulating Endoplasmic Reticulum Stress Signaling.

Solanki NR, Stadanlick JE, Zhang Y, Duc AC, Lee SY, Lauritsen JP, Zhang Z, Wiest DL.

J Immunol. 2016 Sep 15;197(6):2280-9. doi: 10.4049/jimmunol.1600815. Epub 2016 Aug 3.

7.

Ribosomal Protein Rpl22 Controls the Dissemination of T-cell Lymphoma.

Rao S, Cai KQ, Stadanlick JE, Greenberg-Kushnir N, Solanki-Patel N, Lee SY, Fahl SP, Testa JR, Wiest DL.

Cancer Res. 2016 Jun 1;76(11):3387-96. doi: 10.1158/0008-5472.CAN-15-2698. Epub 2016 Apr 5.

8.

Video podcast: Tuberculosis.

Nathan C, Stadanlick J.

Immunol Rev. 2015 Mar;264(1):1. doi: 10.1111/imr.12262. No abstract available.

PMID:
25703547
9.

Video podcast: Adoptive immunotherapy for cancer.

Stadanlick J.

Immunol Rev. 2014 Jan;257(1):6. doi: 10.1111/imr.12145. No abstract available.

PMID:
24329785
10.

Developmental arrest of T cells in Rpl22-deficient mice is dependent upon multiple p53 effectors.

Stadanlick JE, Zhang Z, Lee SY, Hemann M, Biery M, Carleton MO, Zambetti GP, Anderson SJ, Oravecz T, Wiest DL.

J Immunol. 2011 Jul 15;187(2):664-75. doi: 10.4049/jimmunol.1100029. Epub 2011 Jun 20.

11.

Towards a molecular understanding of the differential signals regulating alphabeta/gammadelta T lineage choice.

Lee SY, Stadanlick J, Kappes DJ, Wiest DL.

Semin Immunol. 2010 Aug;22(4):237-46. doi: 10.1016/j.smim.2010.04.008. Epub 2010 May 14. Review.

12.

The BLyS family: toward a molecular understanding of B cell homeostasis.

Treml JF, Hao Y, Stadanlick JE, Cancro MP.

Cell Biochem Biophys. 2009;53(1):1-16. doi: 10.1007/s12013-008-9036-1. Epub 2008 Nov 26. Review.

13.

Tonic B cell antigen receptor signals supply an NF-kappaB substrate for prosurvival BLyS signaling.

Stadanlick JE, Kaileh M, Karnell FG, Scholz JL, Miller JP, Quinn WJ 3rd, Brezski RJ, Treml LS, Jordan KA, Monroe JG, Sen R, Cancro MP.

Nat Immunol. 2008 Dec;9(12):1379-87. doi: 10.1038/ni.1666. Epub 2008 Nov 2.

14.

FcgammaRIIB signals inhibit BLyS signaling and BCR-mediated BLyS receptor up-regulation.

Crowley JE, Stadanlick JE, Cambier JC, Cancro MP.

Blood. 2009 Feb 12;113(7):1464-73. doi: 10.1182/blood-2008-02-138651. Epub 2008 Sep 12.

15.

Homeostatic control of B lymphocyte subsets.

Crowley JE, Scholz JL, Quinn WJ 3rd, Stadanlick JE, Treml JF, Treml LS, Hao Y, Goenka R, O'Neill PJ, Matthews AH, Parsons RF, Cancro MP.

Immunol Res. 2008;42(1-3):75-83. doi: 10.1007/s12026-008-8036-y. Review.

16.

BAFF and the plasticity of peripheral B cell tolerance.

Stadanlick JE, Cancro MP.

Curr Opin Immunol. 2008 Apr;20(2):158-61. doi: 10.1016/j.coi.2008.03.015. Epub 2008 May 2. Review.

17.

TLR stimulation modifies BLyS receptor expression in follicular and marginal zone B cells.

Treml LS, Carlesso G, Hoek KL, Stadanlick JE, Kambayashi T, Bram RJ, Cancro MP, Khan WN.

J Immunol. 2007 Jun 15;178(12):7531-9.

18.

Unraveling the warp and weft of B cell fate.

Stadanlick JE, Cancro MP.

Immunity. 2006 Sep;25(3):395-6.

19.

Space, selection, and surveillance: setting boundaries with BLyS.

Miller JP, Stadanlick JE, Cancro MP.

J Immunol. 2006 Jun 1;176(11):6405-10. Review.

20.

T-cell response relative to genotype and ethnicity during antiviral therapy for chronic hepatitis C.

Kaplan DE, Sugimoto K, Ikeda F, Stadanlick J, Valiga M, Shetty K, Reddy KR, Chang KM.

Hepatology. 2005 Jun;41(6):1365-75.

PMID:
15915458
21.

Homeostatic niche specification among naïve and activated B cells: a growing role for the BLyS family of receptors and ligands.

Crowley JE, Treml LS, Stadanlick JE, Carpenter E, Cancro MP.

Semin Immunol. 2005 Jun;17(3):193-9. Review.

PMID:
15826824
22.

Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection.

Sugimoto K, Ikeda F, Stadanlick J, Nunes FA, Alter HJ, Chang KM.

Hepatology. 2003 Dec;38(6):1437-48.

PMID:
14647055
23.

Influence of ethnicity in the outcome of hepatitis C virus infection and cellular immune response.

Sugimoto K, Stadanlick J, Ikeda F, Brensinger C, Furth EE, Alter HJ, Chang KM.

Hepatology. 2003 Mar;37(3):590-9.

PMID:
12601357
24.

Tissue factor pathway inhibitor binds to platelet thrombospondin-1.

Mast AE, Stadanlick JE, Lockett JM, Dietzen DJ, Hasty KA, Hall CL.

J Biol Chem. 2000 Oct 13;275(41):31715-21.

25.

Solvent/detergent-treated plasma has decreased antitrypsin activity and absent antiplasmin activity.

Mast AE, Stadanlick JE, Lockett JM, Dietzen DJ.

Blood. 1999 Dec 1;94(11):3922-7.

PMID:
10572109

Supplemental Content

Loading ...
Support Center